Mohamad Mdaihly

Dr. Mohamad Mdaihly

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
AYArwa Younis
Arwa Younis
JDJoe Demian
Joe Demian
SBSavannah Bifulco
Savannah Bifulco
LLLauren Lehn
Lauren Lehn
ILIoan Liuba
Ioan Liuba
OWOussama M. Wazni
Oussama M. Wazni
BACKGROUND: Despite the rise of pulsed-field ablation (PFA), predicting and titrating lesion geometry remains challenging. This study aimed to find modifiable parameters that can accurately and repeatedly predict focal PFA lesions across a range of dimensions and to develop a model to predict lesion geometry. METHODS: An in vivo study was performed in 9 swine using an investigational dual-energy contact-force focal catheter with local impedance. Ablations were performed endocardially in the right and left ventricles using settings specifically selected to provide a wide range of lesion dimensions. Predefined PFA applications (1, 2, or 4) were delivered while maintaining different contact-force values (5–45 g). Four different voltages were used (1.0, 1.4, 2.0, and 2.2 kV). Following a 1-week survival period, the animals were euthanized for histopathologic examination. RESULTS: In the study characterization data set, a total of 78 PFA lesions were analyzed. Lesion depth ranged from 1.4 mm to 12.3 mm, while lesion width ranged from 3.3 mm to 21.2 mm. All 3 tested parameters—contact force, number of applications, and voltage—demonstrated a positive linear correlation with lesion depth ( P <0.01). The proposed formula (Focal FARAPULSE Index Model) showed a strong positive correlation with lesion depth ( R =0.83; P <0.0001) and lesion width ( R =0.76; P <0.0001). A perpendicular catheter orientation was correlated with deeper lesions than a parallel orientation. No ST-segment elevations or sustained ventricular arrhythmias were observed. CONCLUSIONS: Our findings demonstrate that PFA can be effectively titrated and predicted using the Focal FARAPULSE Index Model to create lesions of varying depths (1–12 mm), with these results being specific to the proprietary waveform and catheter used.

20 July 2025 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Open access
AYArwa Younis
Arwa Younis
AAAmeer Awashra
Ameer Awashra
MMMaria Matteo
Maria Matteo
AHAyman A. Hussein
Ayman A. Hussein
JDJoe Demian
Joe Demian
TTTyler Taigen
Tyler Taigen
Introduction: Iatrogenic lead perforation is a rare but serious complication of cardiac implantable electronic device (CIED) implantation. Evidence on percutaneous management of subacute or delayed cases remains limited.Methods: We retrospectively reviewed 38 patients treated for iatrogenic lead perforation between January 2012 and October 2024. Acute lead perforation cases, which were managed during the implantation procedure, were excluded. Lead removal was performed under imaging guidance in either the electrophysiology (EP) lab or a hybrid operating room (OR) with surgical backup. Clinical presentation, imaging, procedural approach, and outcomes were analyzed.Results: Of 38 patients, 25 underwent lead removal in the EP lab and 13 in the OR. The mean age was 67 ± 15 years; 58% were female. Most perforated leads were pacemaker leads (58%), typically involving the right ventricle (72%). Complete removal and reimplantation were achieved in all patients using simple traction with or without a locking stylet. Pericardiocentesis was required in 8% of cases. No major complications or delayed events were observed over a median 16‐month follow‐up.Conclusion: Percutaneous removal of perforated leads is feasible and safe in the EP lab when performed by experienced operators. Surgical backup should be readily available given the potential consequences of this complication.

15 August 2026 in Heart Rhythm
Verified
Journal Article
Open access
MMMohamad Mdaihly
Mohamad Mdaihly
PSPasquale Santangeli
Pasquale Santangeli
SBSavannah Bifulco
Savannah Bifulco
LLLauren Lehn
Lauren Lehn
ELEmily Lecy
Emily Lecy
AYArwa Younis
Arwa Younis

24 March 2026 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Open access
MMMohamad Mdaihly
Mohamad Mdaihly
JDJoe Demian
Joe Demian
AKArshneel S. Kochar
Arshneel S. Kochar
DMDavid O. Martin
David O. Martin
ANAravinda Nanjundappa
Aravinda Nanjundappa
TCThomas D. Callahan
Thomas D. Callahan
Background: Transvenous lead extraction (TLE) of old leads is associated with increased procedural complexity and risk due to the development of calcified vascular adhesions. This may necessitate additional tools to free the leads. Shockwave intravenous lithotripsy (IVL), which employs acoustic pressure waves to fracture calcified lesions, has emerged as an adjunctive tool in this setting. However, data on its feasibility in TLE remains limited. Objective: To evaluate the feasibility of IVL as an adjunctive tool in complex TLE cases, focusing on the extraction tools utilized, fluoroscopy duration, success rates, and associated complications. Methods: From a prospectively maintained registry, we analyzed all patients undergoing IVL‐assisted TLE at our institution. These patients were matched to controls without IVL using propensity scores derived from baseline and procedural characteristics, including age, sex, infection indication, age of the oldest explanted lead, number of extracted leads, and number of extracted ICD leads. A matching ratio of 1:3 was applied to increase statistical power while maintaining covariate balance. Results: A total of 27 IVL‐assisted cases were matched to 81 controls. Baseline demographics and comorbidities were well balanced between groups. The mean number of extracted leads and mean age of the oldest extracted lead were comparable (2.44 ± 0.98 vs. 2.49 ± 0.90, p = 0.81; 15.35 ± 5.80 vs. 15.78 ± 8.24 years, p = 0.80). IVL patients demonstrated significantly higher utilization of laser sheaths, either alone (100% vs. 77.7%, p = 0.006) or combined with mechanical tools (44.4% vs. 18.5%, p = 0.008). Median fluoroscopy time was significantly longer in the IVL group (50.2 vs. 15.7 min, p < 0.001). Complete IVL application from the brachiocephalic vein to the superior vena cava was achieved in 20 patients, while 7 were limited by proximal venous stenosis. Procedural and clinical success rates, as well as major and minor complications, were not significantly different between groups. Conclusion: We report the largest series on the use of shockwave IVL during complex TLE cases, with significantly higher fluoroscopy and procedure durations. Despite favorable safety and efficacy outcomes, adjunctive IVL did not confer clear clinical benefit, and the complexity of lead removal remained evident.

18 November 2025 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
MMMohamad Mdaihly
Mohamad Mdaihly
IMIssam Motairek
Issam Motairek
AYArwa Younis
Arwa Younis
CTChadi Tabaja
Chadi Tabaja
JDJoe Demian
Joe Demian
OWOussama M. Wazni
Oussama M. Wazni

30 June 2026 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Open access
IMIssam Motairek
Issam Motairek
ADAli Dakik
Ali Dakik
MMMohamad Mdaihly
Mohamad Mdaihly
CTChadi Tabaja
Chadi Tabaja
BABryan Abadie
Bryan Abadie
WJWael A. Jaber
Wael A. Jaber
Background: Surveillance imaging after left atrial appendage occlusion (LAAO) is recommended to evaluate for peri‐device leak and device‐related thrombus, with both transesophageal echocardiography (TEE) and cardiac computed tomography (CT) considered appropriate modalities. Longitudinal trends in surveillance imaging utilization and modality selection have not been well characterized in large, real‐world populations. Methods: We conducted a retrospective observational study using the TriNetX Research Network, a federated, de‐identified electronic health record database. Adult patients (≥ 18 years) undergoing percutaneous transcatheter LAAO between January 2017 and December 2024 with available imaging data were included. Surveillance imaging was defined as TEE or cardiac CT performed between 45 and 365 days post‐implantation. Annual rates of TEE‐only, CT‐only, and any surveillance imaging were calculated relative to total LAAO volume per year. Temporal trends were assessed using linear regression ( p < 0.05). Results: Among 33 267 patients, the proportion undergoing any surveillance imaging increased from 47.2% in 2017 to 66.6% in 2024 (slope +3.1%/year, p < 0.001). TEE utilization remained stable (slope +0.11%/year, p = 0.68), while CT utilization increased from 2.6% to 22.1% (slope +2.7%/year, p < 0.001). The overall increase in surveillance imaging was driven primarily by CT adoption. Approximately one‐third of patients did not undergo any surveillance imaging within 1 year. Conclusion: Between 2017 and 2024, CT utilization following LAAO increased nearly eightfold while TEE rates remained stable; however, approximately one‐third of patients did not undergo any surveillance imaging within 1 year, revealing a substantial gap in adherence to FDA‐mandated surveillance protocols.